A Costed Framework for the Global Drug Resistant TB Initiative
This document addresses the current progress at the global level in addressing MDR-TB; the global policy environment; the current major global streams of work on MDR-TB; an assessment of what GDI has achieved so far, and, through a limited SWOT analysis, a definition of its comparative advantage within the MDR-TB space. Finally, a budgeted proposal for GDI’s work over the next two years is presented, with an outline of the costs and their justification.
The GDI newsletter Issue 2
The GDI newsletter Issue 1
Presentations from the webinair on the introduction of new DR-TB drugs, 6 August 2015
- Introduction of new drugs
- Active TB drug-safety management & monitoring
- Policies and challenges related to the introduction of new TB drugs